Approximately 2.9 million deaths in 2000 were attributed to the disease.
Read More »Diabetes Drugs Cut Lung Cancer Death Rate
In patients with type 2, or adult-onset, diabetes, treatment with thiazolidinediones (TZDs) may significantly reduce the risk of overall death and death from lung cancer by up to 30%.
Read More »Heart Attack Risk Factors Tied to Kidney Disease
Among people with poor blood sugar control who’ve not yet developed diabetes, heart attack and stroke risk factors account for much of their increased risk of developing kidney disease.
Read More »Apple Shape Predicts Heart Attack Risk Better than BMI
A pot belly increases the risk of a heart attack — even if the rest of the physique is as skinny as a beanpole.
Read More »Continuous Glucose Monitoring Improves Glucose Control
Continuous glucose monitoring may dramatically improve day-to-day management of patients with diabetes, according to new data presented at the European Association for the Study of Diabetes 41st annual meeting.
Read More »Walnuts Improve Lipid Profile in Type 2 Diabetes
Higher intake of fish and nuts can reduce the risk of type 2 diabetes and reduce total and LDL cholesterol.
Read More »Proportion of Cancer Due to Obesity High: Study
In the United States, roughly 10% of all cancers — more than 100,000 cases a year — could be avoided if overweight and obesity did not exist.
Read More »Obesity and Diabetes Independently Linked to Adverse Pregnancy Outcomes
Pre-pregnancy weight above 149 pounds was tied to increased risks of preeclampsia in all ethnic groups. In the combined analysis, increased body weight raised the risk of primary cesarean delivery, but was tied to reduced risk of low birthweight.
Read More »Bezafibrate Slows Onset of Diabetes in Obese Individuals
Treatment with the fibric acid derivative bezafibrate, which influences primary lipid metabolism, reduces the incidence and delays the onset of type 2 diabetes in obese patients.
Read More »Inhaled Insulin May Improve Glycemic Control Without Altering Pulmonary Function
Inhaled insulin improves glycemic control when added to oral agents in type 2 diabetes without altering pulmonary function. Hemoglobin A1C level less than 7% was achieved by 32% of patients receiving inhaled insulin plus oral agents compared with 1% of those receiving oral agent therapy.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.